Requirement of gp130 signaling for the AGM hematopoiesis

Makiko Takizawa, Ikuo Nobuhisa, Katsuhide Igarashi, Masaya Ueno, Kinichi Nakashima, Toshio Kitamura, Tetsuya Taga

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective. Definitive hematopoiesis starts in the aorta-gonad-mesonephros (AGM) region during mouse development and remarkably expands in the liver at a later stage of ontogeny. gp130 is a signal transducing receptor component shared by all the IL-6 family cytokines, whose gene ablation in mouse results in the significant reduction in the fetal liver hematopoiesis. The present study aims to evaluate the role of gp130 signaling in the fetal mouse AGM hematopoiesis. Materials and Methods. Mouse AGM regions from the wild-type and gp130-deficient mice on embryonic day 11.5 were dissociated and cultured with a mixture of cytokines, including one which activates gp130. Wild-type human gp130 and its mutant constructs were introduced into cultured gp130-deficient AGM cells using retrovirus system. To further analyze gp130 downstream signaling, a dominant-negative mutant of STAT3 was also introduced. Results. The gp130 deficiency in the culture of fetal mouse AGM cells resulted in the failure of the expansion of the c-kit+, Sca-1+, and lineage markers- population. Such failure was rescued by introduction of a wild-type gp130 expression construct but not its mutant constructs having no ability to activate STAT3. In the normal AGM cell culture, introduction of a dominant-negative form of STAT3 in which Y705 was changed to phenylalanine suppressed the expansion of hematopoietic cell colonies. Conclusion. gp130 plays an indispensable role in the expansion of hematopoietic precursor cells in the fetal mouse AGM. In particular, the activation of STAT3 by gp130 is found to be important in this process.

Original languageEnglish
Pages (from-to)283-289
Number of pages7
JournalExperimental Hematology
Volume31
Issue number4
DOIs
Publication statusPublished - Apr 1 2003
Externally publishedYes

Fingerprint

Mesonephros
Hematopoiesis
Gonads
Aorta
Multifetal Pregnancy Reduction
Cytokines
Liver
Retroviridae
Phenylalanine
Interleukin-6
Cell Culture Techniques

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Hematology
  • Genetics
  • Cell Biology
  • Cancer Research

Cite this

Takizawa, M., Nobuhisa, I., Igarashi, K., Ueno, M., Nakashima, K., Kitamura, T., & Taga, T. (2003). Requirement of gp130 signaling for the AGM hematopoiesis. Experimental Hematology, 31(4), 283-289. https://doi.org/10.1016/S0301-472X(03)00025-0

Requirement of gp130 signaling for the AGM hematopoiesis. / Takizawa, Makiko; Nobuhisa, Ikuo; Igarashi, Katsuhide; Ueno, Masaya; Nakashima, Kinichi; Kitamura, Toshio; Taga, Tetsuya.

In: Experimental Hematology, Vol. 31, No. 4, 01.04.2003, p. 283-289.

Research output: Contribution to journalArticle

Takizawa, M, Nobuhisa, I, Igarashi, K, Ueno, M, Nakashima, K, Kitamura, T & Taga, T 2003, 'Requirement of gp130 signaling for the AGM hematopoiesis', Experimental Hematology, vol. 31, no. 4, pp. 283-289. https://doi.org/10.1016/S0301-472X(03)00025-0
Takizawa M, Nobuhisa I, Igarashi K, Ueno M, Nakashima K, Kitamura T et al. Requirement of gp130 signaling for the AGM hematopoiesis. Experimental Hematology. 2003 Apr 1;31(4):283-289. https://doi.org/10.1016/S0301-472X(03)00025-0
Takizawa, Makiko ; Nobuhisa, Ikuo ; Igarashi, Katsuhide ; Ueno, Masaya ; Nakashima, Kinichi ; Kitamura, Toshio ; Taga, Tetsuya. / Requirement of gp130 signaling for the AGM hematopoiesis. In: Experimental Hematology. 2003 ; Vol. 31, No. 4. pp. 283-289.
@article{2724ce35c6014afc98eaf977a91cc734,
title = "Requirement of gp130 signaling for the AGM hematopoiesis",
abstract = "Objective. Definitive hematopoiesis starts in the aorta-gonad-mesonephros (AGM) region during mouse development and remarkably expands in the liver at a later stage of ontogeny. gp130 is a signal transducing receptor component shared by all the IL-6 family cytokines, whose gene ablation in mouse results in the significant reduction in the fetal liver hematopoiesis. The present study aims to evaluate the role of gp130 signaling in the fetal mouse AGM hematopoiesis. Materials and Methods. Mouse AGM regions from the wild-type and gp130-deficient mice on embryonic day 11.5 were dissociated and cultured with a mixture of cytokines, including one which activates gp130. Wild-type human gp130 and its mutant constructs were introduced into cultured gp130-deficient AGM cells using retrovirus system. To further analyze gp130 downstream signaling, a dominant-negative mutant of STAT3 was also introduced. Results. The gp130 deficiency in the culture of fetal mouse AGM cells resulted in the failure of the expansion of the c-kit+, Sca-1+, and lineage markers- population. Such failure was rescued by introduction of a wild-type gp130 expression construct but not its mutant constructs having no ability to activate STAT3. In the normal AGM cell culture, introduction of a dominant-negative form of STAT3 in which Y705 was changed to phenylalanine suppressed the expansion of hematopoietic cell colonies. Conclusion. gp130 plays an indispensable role in the expansion of hematopoietic precursor cells in the fetal mouse AGM. In particular, the activation of STAT3 by gp130 is found to be important in this process.",
author = "Makiko Takizawa and Ikuo Nobuhisa and Katsuhide Igarashi and Masaya Ueno and Kinichi Nakashima and Toshio Kitamura and Tetsuya Taga",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S0301-472X(03)00025-0",
language = "English",
volume = "31",
pages = "283--289",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Requirement of gp130 signaling for the AGM hematopoiesis

AU - Takizawa, Makiko

AU - Nobuhisa, Ikuo

AU - Igarashi, Katsuhide

AU - Ueno, Masaya

AU - Nakashima, Kinichi

AU - Kitamura, Toshio

AU - Taga, Tetsuya

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Objective. Definitive hematopoiesis starts in the aorta-gonad-mesonephros (AGM) region during mouse development and remarkably expands in the liver at a later stage of ontogeny. gp130 is a signal transducing receptor component shared by all the IL-6 family cytokines, whose gene ablation in mouse results in the significant reduction in the fetal liver hematopoiesis. The present study aims to evaluate the role of gp130 signaling in the fetal mouse AGM hematopoiesis. Materials and Methods. Mouse AGM regions from the wild-type and gp130-deficient mice on embryonic day 11.5 were dissociated and cultured with a mixture of cytokines, including one which activates gp130. Wild-type human gp130 and its mutant constructs were introduced into cultured gp130-deficient AGM cells using retrovirus system. To further analyze gp130 downstream signaling, a dominant-negative mutant of STAT3 was also introduced. Results. The gp130 deficiency in the culture of fetal mouse AGM cells resulted in the failure of the expansion of the c-kit+, Sca-1+, and lineage markers- population. Such failure was rescued by introduction of a wild-type gp130 expression construct but not its mutant constructs having no ability to activate STAT3. In the normal AGM cell culture, introduction of a dominant-negative form of STAT3 in which Y705 was changed to phenylalanine suppressed the expansion of hematopoietic cell colonies. Conclusion. gp130 plays an indispensable role in the expansion of hematopoietic precursor cells in the fetal mouse AGM. In particular, the activation of STAT3 by gp130 is found to be important in this process.

AB - Objective. Definitive hematopoiesis starts in the aorta-gonad-mesonephros (AGM) region during mouse development and remarkably expands in the liver at a later stage of ontogeny. gp130 is a signal transducing receptor component shared by all the IL-6 family cytokines, whose gene ablation in mouse results in the significant reduction in the fetal liver hematopoiesis. The present study aims to evaluate the role of gp130 signaling in the fetal mouse AGM hematopoiesis. Materials and Methods. Mouse AGM regions from the wild-type and gp130-deficient mice on embryonic day 11.5 were dissociated and cultured with a mixture of cytokines, including one which activates gp130. Wild-type human gp130 and its mutant constructs were introduced into cultured gp130-deficient AGM cells using retrovirus system. To further analyze gp130 downstream signaling, a dominant-negative mutant of STAT3 was also introduced. Results. The gp130 deficiency in the culture of fetal mouse AGM cells resulted in the failure of the expansion of the c-kit+, Sca-1+, and lineage markers- population. Such failure was rescued by introduction of a wild-type gp130 expression construct but not its mutant constructs having no ability to activate STAT3. In the normal AGM cell culture, introduction of a dominant-negative form of STAT3 in which Y705 was changed to phenylalanine suppressed the expansion of hematopoietic cell colonies. Conclusion. gp130 plays an indispensable role in the expansion of hematopoietic precursor cells in the fetal mouse AGM. In particular, the activation of STAT3 by gp130 is found to be important in this process.

UR - http://www.scopus.com/inward/record.url?scp=0037383580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037383580&partnerID=8YFLogxK

U2 - 10.1016/S0301-472X(03)00025-0

DO - 10.1016/S0301-472X(03)00025-0

M3 - Article

VL - 31

SP - 283

EP - 289

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 4

ER -